KOSS CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that KOSS CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $23.52M | Aug 23, 2018 |
| FY2018 | Jun 30, 2017 | $24.05M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $26.00M | Aug 25, 2017 |
| FY2016 | Jun 30, 2015 | $24.23M | Aug 25, 2016 |
| FY2015 | Jun 30, 2014 | $23.84M | Aug 28, 2015 |
| FY2014 | Jun 30, 2013 | $35.76M | Aug 28, 2014 |
| FY2013 | Jun 30, 2012 | $37.87M | Aug 23, 2013 |
| FY2012 | Jun 30, 2011 | $41.52M | Aug 27, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $4.77M | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | $4.19M | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $4.46M | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | $6.72M | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $6.73M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $5.66M | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | $6.82M | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $6.56M | Aug 30, 2019 |
| FY2018 | Jun 30, 2017 | $6.90M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $8.94M | Aug 25, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($874.8K) | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | ($950.9K) | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $8.32M | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | $1.27M | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $493.6K | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | ($465.6K) | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | $306.0K | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | ($3.41M) | Aug 30, 2019 |
| FY2018 | Jun 30, 2017 | ($963.6K) | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $1.39M | Aug 25, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($1.74M) | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | ($1.87M) | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | ($24.88M) | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | $902.0K | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | ($390.5K) | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | ($484.0K) | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | $276.3K | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | ($364.2K) | Aug 30, 2019 |
| FY2015 | Jun 30, 2015 | $512.8K | Aug 28, 2015 |
| FY2015 | Jun 30, 2014 | ($10.00M) | Aug 28, 2015 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $213.9K | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | $238.1K | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $288.2K | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | $285.2K | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $410.6K | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $397.4K | Aug 20, 2021 |
| FY2018 | Jun 30, 2018 | $427.0K | Aug 23, 2018 |
| FY2018 | Jun 30, 2017 | $213.7K | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $91.3K | Aug 25, 2017 |
| FY2016 | Jun 30, 2015 | $0 | Aug 25, 2016 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $6.51M | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | $6.06M | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $29.34M | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | $5.81M | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $7.12M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $6.15M | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | $6.54M | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $6.92M | Aug 30, 2019 |
| FY2018 | Jun 30, 2017 | $7.60M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $7.96M | Aug 25, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($214.9K) | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | ($190.5K) | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $10.74M | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | ($942.5K) | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $348.7K | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $1.80M | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | $1.41M | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $1.03M | Aug 30, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $490.7K | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | $461.8K | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $98.4K | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | $108.2K | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $600.2K | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $424.2K | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | $187.8K | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $250.6K | Aug 30, 2019 |
| FY2018 | Jun 30, 2017 | $403.4K | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $449.8K | Aug 25, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $37.18M | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | $37.20M | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $39.09M | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | $29.96M | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $26.32M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $22.58M | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | $23.24M | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $22.78M | Aug 30, 2019 |
| FY2018 | Jun 30, 2017 | $23.42M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $24.12M | Aug 25, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $6.57M | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | $6.05M | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $7.28M | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | $7.26M | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $6.75M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $7.42M | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | $8.16M | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $8.57M | Aug 30, 2019 |
| FY2018 | Jun 30, 2017 | $5.85M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $5.93M | Aug 25, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $30.61M | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | $31.15M | Aug 29, 2025 |
| FY2025 | Jun 30, 2023 | $31.81M | Aug 29, 2025 |
| FY2024 | Jun 30, 2022 | $23.03M | Aug 30, 2024 |
| FY2023 | Jun 30, 2021 | $19.58M | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | $15.16M | Aug 26, 2022 |
| FY2021 | Jun 30, 2019 | $15.07M | Aug 20, 2021 |
| FY2020 | Jun 30, 2018 | $14.20M | Aug 27, 2020 |
| FY2019 | Jun 30, 2017 | $17.57M | Aug 30, 2019 |
| FY2018 | Jun 30, 2016 | $18.19M | Aug 23, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $16.82M | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | $17.70M | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $18.65M | Aug 30, 2024 |
| FY2024 | Jun 30, 2022 | $10.33M | Aug 30, 2024 |
| FY2022 | Jun 30, 2021 | $8.73M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $8.24M | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | $8.70M | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | $8.41M | Aug 30, 2019 |
| FY2018 | Jun 30, 2017 | $12.11M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | $13.08M | Aug 25, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.81M | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | $2.84M | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $3.09M | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | $9.21M | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $6.95M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | $4.00M | Aug 20, 2021 |
| FY2021 | Jun 30, 2019 | $2.23M | Aug 20, 2021 |
| FY2019 | Jun 30, 2018 | $1.08M | Aug 30, 2019 |
| FY2019 | Jun 30, 2017 | $432.3K | Aug 30, 2019 |
| FY2018 | Jun 30, 2016 | $735.4K | Aug 23, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Aug 30, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Aug 25, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Aug 30, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Aug 25, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 9.46M | Aug 29, 2025 |
| FY2025 | Jun 30, 2024 | 9.30M | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | 9.23M | Aug 30, 2024 |
| FY2023 | Jun 30, 2022 | 9.15M | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | 8.61M | Aug 26, 2022 |
| FY2021 | Jun 30, 2020 | 7.40M | Aug 20, 2021 |
| FY2020 | Jun 30, 2019 | 7.38M | Aug 27, 2020 |
| FY2019 | Jun 30, 2018 | 7.38M | Aug 30, 2019 |
| FY2018 | Jun 30, 2017 | 7.38M | Aug 23, 2018 |
| FY2017 | Jun 30, 2016 | 7.38M | Aug 25, 2017 |